Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-07-27

Clinical Trial Update: Dextenza With ILUX for Treatment of MGD [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for Dextenza with ILUX in Meibomian Gland Dysfunction and Evaporative Dry Eye has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dextenza with ILUX

Snippet

Sponsor: Warrenville Eyecare | Conditions: Meibomian Gland Dysfunction, Evaporative Dry Eye | Phase 4 | Status: COMPLETED